Abstract
A significantly simpler analog of the natural product migrastatin, termed migrastatin ether (ME), has been prepared and evaluated. Both in vivo and in vitro studies indicate that ME exhibits a concentration-dependent inhibitory effect on migration of breast cancer cells.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antineoplastic Agents / chemical synthesis
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / pharmacology*
-
Antineoplastic Agents / therapeutic use
-
Biological Products / chemistry*
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / pathology
-
Cell Movement / drug effects*
-
Drug Screening Assays, Antitumor
-
Ethers / chemical synthesis
-
Ethers / chemistry
-
Ethers / pharmacology*
-
Ethers / therapeutic use
-
Female
-
Humans
-
Macrolides / chemistry
-
Macrolides / pharmacology*
-
Macrolides / therapeutic use
-
Mice
-
Molecular Conformation
-
Neoplasm Metastasis / drug therapy*
-
Neoplasm Metastasis / pathology
-
Piperidones / chemistry
-
Piperidones / pharmacology*
-
Piperidones / therapeutic use
-
Stereoisomerism
Substances
-
Antineoplastic Agents
-
Biological Products
-
Ethers
-
Macrolides
-
Piperidones
-
migrastatin